First Time Loading...

Enfusion Inc
NYSE:ENFN

Watchlist Manager
Enfusion Inc Logo
Enfusion Inc
NYSE:ENFN
Watchlist
Price: 9.25 USD 0.22% Market Closed
Updated: Mar 29, 2024

Intrinsic Value

Enfusion, Inc. engages in the development of cloud-native multi-tenant software for alternative and institutional investment managers. [ Read More ]

The intrinsic value of one ENFN stock under the Base Case scenario is 7.04 USD. Compared to the current market price of 9.25 USD, Enfusion Inc is Overvalued by 24%.

Key Points:
ENFN Intrinsic Value
Base Case
7.04 USD
Overvaluation 24%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Enfusion Inc

Backtest ENFN Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ENFN stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Enfusion Reports Strong Q4 Growth and Client Expansion
2023-Q4 Earnings Call

Enfusion Reports Strong Q4 Growth and Client Expansion

Enfusion, in Q4 2023, showcased significant growth and predictability in its economic profile, with a 15% increase in revenue to $46.5 million and adjusted EBITDA hitting $9.8 million, marking a 21% margin and a 436-basis point year-over-year expansion. For the full year, revenue rose to $174.5 million, up 16%, and adjusted EBITDA improved by approximately 500 basis points to 18%. The quarter brought 45 new client additions, lifting the total count to 865 and average contract value (ACV) to $219,000, records for Enfusion. Key wins included the Utah Retirement Systems and Mariner Investment Group in the Americas, with regional revenues growing 15% year-over-year, while European revenues surged 24% with the onboardings of an asset manager in Belgium and a large Swedish family office. In APAC, a 7% revenue growth stemmed from a significant client conversion in South Korea, asserting Enfusion's market presence amid geopolitical challenges.

Financials

Balance Sheet Decomposition
Enfusion Inc

Current Assets 69.9m
Cash & Short-Term Investments 35.6m
Receivables 28.1m
Other Current Assets 6.2m
Non-Current Assets 39.1m
PP&E 32.6m
Other Non-Current Assets 6.5m
Current Liabilities 20.3m
Accounts Payable 2.2m
Accrued Liabilities 18.1m
Non-Current Liabilities 35m
Other Non-Current Liabilities 35m
Efficiency

Earnings Waterfall
Enfusion Inc

Revenue
174.5m USD
Cost of Revenue
-57.6m USD
Gross Profit
116.9m USD
Operating Expenses
-104.9m USD
Operating Income
11.9m USD
Other Expenses
-5.6m USD
Net Income
6.3m USD

Free Cash Flow Analysis
Enfusion Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

ENFN Profitability Score
Profitability Due Diligence

Enfusion Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 1-Year Revenue Growth
Positive ROIC
Positive ROE
35/100
Profitability
Score

Enfusion Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

ENFN Solvency Score
Solvency Due Diligence

Enfusion Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Short-Term Solvency
Long-Term Solvency
74/100
Solvency
Score

Enfusion Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ENFN Price Targets Summary
Enfusion Inc

Wall Street analysts forecast ENFN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ENFN is 9.99 USD with a low forecast of 8.08 USD and a high forecast of 12.6 USD.

Lowest
Price Target
8.08 USD
13% Downside
Average
Price Target
9.99 USD
8% Upside
Highest
Price Target
12.6 USD
36% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

ENFN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

ENFN Price
Enfusion Inc

1M 1M
+7%
6M 6M
+3%
1Y 1Y
-10%
3Y 3Y
-53%
5Y 5Y
-53%
10Y 10Y
-53%
Annual Price Range
9.25
52w Low
7.54
52w High
11.45
Price Metrics
Average Annual Return -20.43%
Standard Deviation of Annual Returns 39.87%
Max Drawdown -67%
Shares Statistics
Market Capitalization 831.3m USD
Shares Outstanding 89 871 104
Percentage of Shares Shorted 3.6%

ENFN Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Enfusion Inc Logo
Enfusion Inc

Country

United States of America

Industry

Technology

Market Cap

831.3m USD

Dividend Yield

0%

Description

Enfusion, Inc. engages in the development of cloud-native multi-tenant software for alternative and institutional investment managers. The company is headquartered in Chicago, Illinois. The company went IPO on 2021-10-21. The products and services that comprise its solution are designed to enable investment managers to take investment decisions in real time. The Company’s solution, comprised of mission critical systems integrated with a suite of technology-powered, managed services, serves the full investment lifecycle, drives insights into and control over the business activities of the investment manager and investment operations. Its solution’s end-to-end functionality includes Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System and Enfusion Analytics System. PMS able to comprehensively construct and re-balance investment portfolios, this system generates a real-time investment book of record. PMS module offers portfolio managers, traders, compliance teams and analysts the ability to electronically communicate trade orders.

Contact

ILLINOIS
Chicago
125 South Clark Street, Suite 750
+13122539800.0
https://enfusion.com/

IPO

2021-10-21

Employees

798

Officers

CEO & Director
Mr. Oleg Movchan
Chief Financial Officer
Mr. Bradley Herring
Chief People Officer
Ms. Bronwen Bastone
Managing Partner
Mr. Stephen Malherbe
Chief Operating Officer
Mr. Neal Pawar
Chief Accounting Officer
Ms. Valeria Gutowski
Show More
Head of Investor Relations
Mr. Ignatius Tochukwu Njoku
General Counsel
Matt Campobasso
Global Head of Managed Services Production
Mr. Joseph Defeo
Head of Implementation
Mr. Jeff Young
Show Less

See Also

Discover More
What is the Intrinsic Value of one ENFN stock?

The intrinsic value of one ENFN stock under the Base Case scenario is 7.04 USD.

Is ENFN stock undervalued or overvalued?

Compared to the current market price of 9.25 USD, Enfusion Inc is Overvalued by 24%.